← Search & browse all drugs
DERMATOLOGICALS › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › Anesthetics for topical use
tetracaine
D04AB06
Forms & Strengths
- Ophthalmic Solution: 0.5%
- Topical Gel: 2%
- Topical Cream: 0.5%
- Topical Solution: 2%
Adult Dosing
- Ophthalmic: 1 to 2 drops into the eye(s) prior to minor surgical procedures
- Topical: Apply a small amount to the affected area as needed for pain or pruritus
Pediatric Dosing
- Ophthalmic: 1 drop into the eye(s) prior to minor procedures (use with caution in neonates and infants)
- Topical: Safety and efficacy not well established in pediatric patients; use minimal effective dose
Indications
- Local anesthesia for ophthalmic procedures
- Temporary relief of pain and itching associated with minor skin irritations or sunburn
Mechanism of Action
- Estrogen-related local anesthetic of the ester type
- Stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthesia
Contraindications
- Hypersensitivity to tetracaine, other ester-type local anesthetics, or para-aminobenzoic acid (PABA) derivatives
- Administration into or through infected or inflamed areas
Adverse Reactions
- Transient stinging, burning, or irritation upon instillation
- Corneal epithelium damage with prolonged or frequent use (ophthalmic)
- Contact dermatitis, erythema, or edema at the application site
- Systemic toxicity (central nervous system and cardiovascular) with excessive absorption
Drug Interactions
- Sulfonamides: Local anesthetics of the PABA ester type may inhibit the antibacterial action of sulfonamides
- Cholinesterase inhibitors: May decrease the metabolism of ester local anesthetics, increasing the risk of systemic toxicity
Curated Content: Needs Vetting Before Put to Clinical Use